Entdecken Sie die besten Kosten und Kliniken für die Behandlung von Brustkrebs in Lettland 2026

The Latvian Oncology Center at Riga East Clinical University Hospital handles 80% of cancer cases. It features a specialized breast unit with multidisciplinary teams. Pauls Stradins Clinical University Hospital is also a primary site. These facilities provide surgery, chemotherapy, and radiation within European standards.

• Primary center: Latvian Oncology Center in Riga is the largest specialized facility.
• Specialized surgery: Private clinics like Oncoclinic in Riga specialize in surgical oncological treatment.
• Integrative care: Pallas Clinic in Jurmala offers licensed oncology plans combining various therapies.
• Regional access: Liepaja Regional Hospital provides examination and treatment in western Latvia.

Bookimed Expert Insight: While major state hospitals like Pauls Stradins handle the highest patient volumes, specialized outpatient clinics offer unique expertise. Dr. Inta Jaunalksne at Pallas Clinic brings over 30 years of experience from her time heading the Clinical Immunology Center at a major university hospital. This allows smaller clinics to provide highly specialized immunological support that often complements standard surgical protocols found at larger institutions.

Patient Consensus: Patients note that state hospitals like Gailezers are the main hubs for treatment, but waitlists can reach three months. They emphasize getting a state-insured referral early to avoid high private costs and suggest bringing a translator for smoother communication.

Latvian oncology centers provide comprehensive surgical options including breast-conserving lumpectomy and total mastectomy. Specialized facilities like Pauls Stradins Clinical University Hospital perform nipple-sparing and skin-sparing techniques. These methods aim to preserve the natural breast envelope for immediate reconstruction or aesthetic results.

• Oncoplastic surgery: Surgeons use tumor remodeling to maintain breast shape during lumpectomies.
• Sentinel node biopsy: Minimally invasive mapping identifies early cancer spread to avoid arm swelling.
• Advanced reconstruction: Microsurgical centers offer DIEP and LD flaps using a patient's own tissue.
• Intraoperative radiotherapy: Riga East Hospital delivers targeted radiation during surgery to reduce treatment time.

Bookimed Expert Insight: While the public health system offers rapid surgical access within two weeks, patients seeking superior cosmetic outcomes often choose private clinics. Specialists like Dr. Inta Jaunalksne at Pallas Clinic combine conventional oncology with immunology expertise. This dual focus supports long-term recovery and immune system health after invasive procedures.

Patient Consensus: Patients emphasize asking specifically for sentinel lymph node biopsy to prevent long-term lymphedema. Many note that while public surgery is fast, private options are preferred for better aesthetic symmetry and breast reshaping.

State-funded breast reconstruction is available in Latvia through a government-reimbursed program. It covers post-mastectomy procedures for oncological patients at specific clinical centers. Access depends on annual national quotas. These quotas often exhaust before the year ends, leading to significant wait times.

• Available facilities: Services are provided at Riga East Clinical University Hospital (RAKUS).
• Specialized centers: Pauls Stradins Clinical University Hospital also performs these reconstructive operations.
• Eligibility criteria: Funding applies primarily to patients requiring reconstruction after cancer-related mastectomies.
• Program limitations: State reimbursement generally excludes purely prophylactic surgeries without a diagnosis.

Bookimed Expert Insight: Clinical data shows a high concentration of expertise in Riga. Dr. Inta Jaunalksne, who leads the Clinical Immunology Center at Pauls Stradins Hospital, brings over 30+ years of experience to oncology-related care. Patients should note that while these large public hospitals handle reconstruction, smaller private clinics like Pallas Clinic in Jūrmala focus more on specialized integrative therapies and rehabilitation rather than surgical rebuilding.

Patient Consensus: Patients note that while basic mastectomies are covered, advanced aesthetic reconstruction often involves waitlists of 6 to 12 months. Many suggest budgeting for private care to avoid emotional delays or checking cross-border funding options via the EU health card.

Virotherapy uses oncolytic viruses to infect and destroy malignant cells while sparing healthy tissue. The virus replicates inside tumors until they burst. This process helps the immune system recognize and attack cancer. In Latvia, specific virotherapy drug distributions were suspended in 2019.

• Treatment mechanism: Viruses selectively target tumor cells to trigger a systemic immune response.
• Regulatory status: The Latvian State Agency of Medicines suspended Rigvir distribution in March 2019.
• Clinical providers: Pallas Clinic in Jūrmala offers integrative oncology including immunology and virotherapy.
• Expert availability: Dr. Inta Jaunalksne specializes in virotherapy and clinical immunology in Jūrmala.

Bookimed Expert Insight: While traditional virotherapy drug access changed in Latvia, the expertise remains concentrated in Jūrmala. Dr. Inta Jaunalksne at Pallas Clinic brings over 30 years of experience. This clinic treat 100 oncology patients annually using integrative plans. These plans combine immunology with advanced medicinal therapeutic products. Specialists here often serve international patients from Europe and CIS countries. This suggests a continued regional focus on specialized immune-based protocols.

Patient Consensus: Patients compare the treatment to giving the cancer a targeted flu. Many note it is often better tolerated than intensive therapies like CAR-T. Typical feedback mentions manageable flu-like side effects that may last several weeks.

Latvia offers specialized oncology care but faces challenges compared to EU averages. The country maintains the third-highest cancer death rate in the bloc. While general mortality is high, five-year survival for lung cancer reaches 20.4%. This significantly exceeds the 15% EU average for that specific diagnosis.

• Early detection: Only 42% of breast cancers are caught early versus 56% EU average.
• Treatment access: New cancer drug delays average 930 days, nearly double the EU norm.
• Financial investment: Per capita cancer spending is €81, well below the €164 EU average.
• Diagnostic speed: Latvia introduced a green corridor system to prioritize and accelerate specialist referrals.
• Expertise levels: Leading specialists like Dr. Inta Jaunalksne have over 30 years of experience.

Bookimed Expert Insight: Data suggests specialized immunology is a primary differentiator for Latvian private care. Pallas Clinic in Jūrmala treats approximately 100 international patients annually. They use advanced products like CIK cells and Dendritic Cell Therapy. High-volume public centers like Pauls Stradiņš Clinical University Hospital remain centers for complex surgery.

Patient Consensus: Patients note that while surgical skill is high, wait times can reach several months. Many choose private clinics in Riga to avoid delays in starting chemotherapy or immunotherapy. They often recommend seeking second opinions in Germany or Estonia to access specific targeted drugs.